Keywords: neurogen, s-p, complete, ph, schizophrenia, trial, corp

Neurogen And S-P Complete Ph I Schizophrenia Trial

Article | 10 April 1997

Print This

- Neurogen Corp and partner Schering-Plough have completed a Phase Itrial with the dopamine D4 antagonist NGD 94-4, for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in